IMBiologics

아이엠바이오로직스 · 493280

Health Care Biotechnology · KOSDAQ

Small-cap

Market cap US$308.4M (₩425.5B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$8.4M
Operating profit · FY2025
US$215.7K
Net income · FY2025
US$635.4K

Revenue

  • FY2025US$8.4M

Operating profit

  • FY2025US$215.7K

Net income

  • FY2025US$635.4K

Key ratios (FY2025)

ROE
1.2%
Debt/Eq
2.5%
Op. margin
2.6%
Net margin
7.5%
Rev. YoY
N/A (see filing)

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.